18F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy:
Reads0
Chats0
TLDR
In this article, the authors evaluated the prognostic value of 18F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (18F-FDG PET/CT) performed before and after the insertion of positron positron emissions.Abstract:
Background and Aims:This study evaluated the prognostic value of 18F-fluorodeoxyglucose positron emission tomography with integrated computed tomography (18F-FDG PET/CT) performed before and after ...read more
Citations
More filters
Journal ArticleDOI
Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
Ricarda Hinzpeter,Seyed Ali Mirshahvalad,R. Kulanthaivelu,Claudia Ortega,Ur Metser,ZhihuiAmy Liu,Elena Elimova,Rebecca Wong,J. Yeung,Raymond Woo-Jun Jang,Patrick Veit-Haibach +10 more
TL;DR: In this paper , the authors investigated whether combining clinical parameter, PET and CT radiomics with sarcopenic status, derived from standard of care clinical 18F-FDG-PET/CT improves outcome prognostication among patients with advanced, metastatic esophageal and gastroesophageaal cancer.
Journal ArticleDOI
18F-FDG PET/CT for Identifying the Potential Primary Diseases and Predicting Prognosis of Secondary Hemophagocytic Lymphohistiocytosis in Children
Ang Wei,Xia Lu,Honghao Ma,Hongyun Lian,Xuan Yang,Liping Zhang,Dong Wang,Si-Cheng Chen,Qing Zhang,Zhigang Li,Rui Zhang,Jigang Yang,Tianyou Wang +12 more
TL;DR: It is concluded that some 18F-FDG PET/CT metabolic parameters can help identify the etiology of sHLH in children and provide directions for further inspection.
Journal ArticleDOI
Can 18F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?
V. Jayaprakasam,Peter Charles Gibbs,Natalie Gangai,Raazi Bajwa,Ramon E. Sosa,Randy Yeh,Megan Greally,Geoffrey Y. Ku,Marc J. Gollub,Viktoriya Paroder +9 more
TL;DR: In a final cohort of 74 patients, it is found that the developed radiomics models can predict these clinical and prognostic outcomes with reasonable accuracy, similar or better than those derived from conventional imaging.
Journal ArticleDOI
Tumor cell-derived exosomal lncRNA LOC441178 inhibits the tumorigenesis of esophageal carcinoma through suppressing macrophage M2 polarization
TL;DR: The delivery of LOC441178 by EC cell-secreted exosomes inhibited the tumorigenesis of EC by suppressing the polarization of M2 macrophages and may provide a new theoretical basis for discovering new strategies against EC.
Journal ArticleDOI
Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
Weihong Feng,Ying-Yi Chen,Yen-Shou Kuo,Kuan-Hsun Lin,Yuan-Ming Tsai,Ti-Hui Wu,Hsu-Kai Huang,Tsai-Wang Huang +7 more
TL;DR: In this paper , the authors aimed to determine the pathological complete response (pCR), overall survival (OS), and disease-free survival (DFS) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) using post-neoadjuvant chemoradiotherapy (nCRT) F-18-fluorodeoxyglucose (18FDG).
References
More filters
Journal ArticleDOI
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
Hinrich Wieder,Björn L.D.M. Brücher,Frank B. Zimmermann,Karen Becker,Florian Lordick,Ambros J. Beer,Markus Schwaiger,Ulrich Fink,Jörg Rüdiger Siewert,Hubert J. Stein,Wolfgang A. Weber +10 more
TL;DR: Changes in tumor metabolic activity after 14 days of preoperative chemoradiotherapy are significantly correlated with tumor response and patient survival, and suggests that FDG-PET might be used to identify nonresponders early during neoadjuvant cheMoradiotherapy, allowing for early modifications of the treatment protocol.
Journal ArticleDOI
Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma
Seung Hyup Hyun,Joon Young Choi,Young Mog Shim,Kwhanmien Kim,Su Jin Lee,Young Seok Cho,Ji Young Lee,Kyung-Han Lee,Byung Tae Kim +8 more
TL;DR: MTV, a volumetric parameter of 18F-FDG PET, is an important independent prognostic factor for survival and a better predictor of survival than SUVmax for the primary tumor in patients with esophageal carcinoma.
Journal ArticleDOI
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
Christian Meyer zum Büschenfelde,Ken Herrmann,T. Schuster,Hans Geinitz,Rupert Langer,Karin Becker,Katja Ott,Matthias Ebert,Frank Zimmermann,Helmut Friess,Markus Schwaiger,Christian Peschel,Florian Lordick,Bernd J. Krause +13 more
TL;DR: Compared with the previous published MUNICON (Metabolic response evalUatioN for Individualisation of neoadjuvant Chemotherapy in Esophageal and esophagogastric adeNocarcinoma) I trial, increased histopathologic response was observed after salvage radiochemotherapy, but the primary endpoint of the study to increase the R0 resection rate was not met.
Journal ArticleDOI
Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.
TL;DR: The present meta-analysis comprehensively review the evidence for use of standardized uptake value (SUV) measured on tumor to predict prognosis of esophageal cancer to anticipate that SUV could be used in patients with esphageal carcinoma.
Journal ArticleDOI
Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
Xiaojun Zhong,Jinming Yu,Baijiang Zhang,Dianbin Mu,Weidi Zhang,Daotang Li,Anqin Han,Pingping Song,Hui Li,Guoren Yang,Feng Ming Kong,Zheng Fu +11 more
TL;DR: The optimal PET method to estimate the length of gross tumor varies with tumor length and SUV(max); an SUV cutoff of 2.5 provided the closest estimation in this study.